Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease
Abstract
:1. Introduction
2. Results
3. Discussion
4. Methods and Materials
4.1. Abstract Collection
4.2. Prediction of MicroRNAs’ Target Genes
4.3. Network and Functional Enrichment Analysis
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Hiscott, J.; Alexandridi, M.; Muscolini, M.; Tassone, E.; Palermo, E.; Soultsioti, M.; Zevini, A. The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev. 2020, 53, 1–9. [Google Scholar] [CrossRef]
- World Health Organization. Available online: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---22-june-2022 (accessed on 25 June 2022).
- Mir, T.; Almas, T.; Kaur, J.; Faisaluddin, M.; Song, D.; Ullah, W.; Mamtani, S.; Rauf, H.; Yadav, S.; Latchana, S.; et al. Coronavirus disease 2019 (COVID-19): Multisystem review of pathophysiology. Ann. Med. Surg. 2021, 69, 102745. [Google Scholar] [CrossRef]
- Roberts, C.M.; Levi, M.; McKee, M.; Schilling, R.; Lim, W.S.; Grocott, M. COVID-19: A complex multisystem disorder. Br. J. Anaesth. 2020, 125, 238–242. [Google Scholar] [CrossRef] [PubMed]
- Kgatle, M.M.; Lawal, I.O.; Mashabela, G.; Boshomane, T.M.G.; Koatale, P.C.; Mahasha, P.W.; Ndlovu, H.; Vorster, M.; Rodrigues, H.G.; Zeevaart, J.R.; et al. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks. Front. Immunol. 2021, 8, 752380. [Google Scholar] [CrossRef]
- Mahmudpour, M.; Roozbeh, J.; Keshavarz, M.; Farrokhi, S.; Nabipour, I. COVID-19 cytokine storm: The anger of inflammation. Cytokine 2020, 133, 155151. [Google Scholar] [CrossRef]
- Fajgenbaum, D.C.; June, C.H. Cytokine Storm. N. Engl. J. Med. 2020, 383, 2255–2273. [Google Scholar] [CrossRef]
- Park, J.; Foox, J.; Hether, T.; Danko, D.C.; Warren, S.; Kim, Y.; Reeves, J.; Butler, D.J.; Mozsary, C.; Rosiene, J.; et al. System-wide transcriptome damage and tissue identity loss in COVID-19 patients. Cell Rep. 2022, 3, 100522. [Google Scholar] [CrossRef]
- Delorey, T.M.; Ziegler, C.G.K.; Heimberg, G.; Normand, R.; Yang, Y.; Segerstolpe, A.; Abbondanza, D.; Fleming, S.J.; Subramanian, A.; Montoro, D.T.; et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 2021, 595, 107–113. [Google Scholar] [CrossRef]
- Oliveto, S.; Mancino, M.; Manfrini, N.; Biffo, S. Role of microRNAs in translation regulation and cancer. WJBC 2017, 8, 45–56. [Google Scholar] [CrossRef]
- Fuchs Wightman, F.; Giono, L.E.; Fededa, J.P.; de la Mata, M. Target RNAs Strike Back on MicroRNAs. Front Genet. 2018, 9, 435. [Google Scholar] [CrossRef]
- Ardekani, A.M.; Naeini, M.M. The Role of MicroRNAs in Human Diseases. Avicenna J. Med. Biotechnol. 2010, 2, 161–179. [Google Scholar] [PubMed]
- Drury, R.E.; O’Connor, D.; Pollard, A.J. The Clinical Application of MicroRNAs in Infectious Disease. Front. Immunol. 2017, 8, 1182. [Google Scholar] [CrossRef] [PubMed]
- Akula, S.M.; Bolin, P.; Cook, P.P. Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene. RNA Biol. 2022, 19, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Trobaugh, D.W.; Klimstra, W.B. MicroRNA Regulation of RNA Virus Replication and Pathogenesis. Trends Mol. Med. 2017, 23, 80–93. [Google Scholar] [CrossRef]
- Li, C.; Wang, R.; Wu, A.; Yuan, T.; Song, K.; Bai, Y.; Liu, C. SARS-CoV-2 as potential microRNA sponge in COVID-19 patients. BMC Med. Genom. 2022, 15, 94. [Google Scholar] [CrossRef]
- Wang, Y.; Zhu, X.; Jiang, X.M.; Guo, J.; Fu, Z.; Zhou, Z.; Yang, P.; Guo, H.; Guo, X.; Liang, G.; et al. Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients. Signal Transduct. Target. Ther. 2021, 6, 300. [Google Scholar] [CrossRef]
- Paul, S.; Bravo Vázquez, L.A.; Reyes-Pérez, P.R.; Estrada-Meza, C.; Aponte Alburquerque, R.A.; Pathak, S.; Banerjee, A.; Bandyopahyay, A.; Chakraborty, S.; Srivastava, A. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review. Virus Res. 2022, 308, 198631. [Google Scholar] [CrossRef]
- Farr, R.J.; Rootes, C.L.; Rowntree, L.C.; Nguyen, T.H.O.; Hensen, L.; Kedzierski, L.; Cheng, A.C.; Kedzierska, K.; Au, G.G.; Marsh, G.A.; et al. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog. 2021, 17, e1009759. [Google Scholar] [CrossRef]
- Arisan, E.D.; Dart, A.; Grant, G.H.; Arisan, S.; Cuhadaroglu, S.; Lange, S.; Uysal-Onganer, P. The Prediction of miRNAs in SARS-CoV-2 Genomes: Hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways. Viruses 2020, 12, 614. [Google Scholar] [CrossRef]
- Yousefi, H.; Poursheikhani, A.; Bahmanpour, Z.; Vatanmakanian, M.; Taheri, M.; Mashouri, L.; Alahari, S.K. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach. Biomed. Pharm. 2020, 130, 110548. [Google Scholar] [CrossRef]
- Chow, J.T.; Salmena, L. Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium. Genes 2020, 11, 1002. [Google Scholar] [CrossRef] [PubMed]
- Haddad, H.; Walid, A.Z. miRNA target prediction might explain the reduced transmission of SARS-CoV-2 in Jordan, Middle East. Noncoding RNA Res. 2020, 5, 135–143. [Google Scholar] [CrossRef] [PubMed]
- Alam, T.; Lipovich, L. miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery. Noncoding RNA 2021, 7, 18. [Google Scholar] [CrossRef]
- Teodori, L.; Sestili, P.; Madiai, V.; Coppari, S.; Fraternale, D.; Rocchi, M.; Ramakrishna, S.; Albertini, M.C. MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti-COVID-19 Therapeutics. Front. Pharmacol. 2020, 11, 582003. [Google Scholar] [CrossRef]
- Hum, C.; Loiselle, J.; Ahmed, N.; Shaw, T.A.; Toudic, C.; Pezacki, J.P. MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19. Drugs 2021, 81, 517–531. [Google Scholar] [CrossRef]
- Kim, W.R.; Park, E.G.; Kang, K.W.; Lee, S.M.; Kim, B.; Kim, H.S. Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2. Mol. Cells. 2020, 43, 953–963. [Google Scholar] [CrossRef]
- Khan, M.A.; Sany, M.; Islam, M.S.; Islam, A. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19. Front. Genet. 2020, 11, 765. [Google Scholar] [CrossRef]
- Sardar, R.; Satish, D.; Birla, S.; Gupta, D. Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections. Data Brief 2020, 32, 106207. [Google Scholar] [CrossRef]
- Pierce, J.B.; Simion, V.; Icli, B.; Pérez-Cremades, D.; Cheng, H.S.; Feinberg, M.W. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs. Genes 2020, 11, 1354. [Google Scholar] [CrossRef]
- Jafarinejad-Farsangi, S.; Jazi, M.M.; Rostamzadeh, F.; Hadizadeh, M. High affinity of host human microRNAs to SARS-CoV-2 genome: An in silico analysis. Noncoding RNA Res. 2020, 5, 222–231. [Google Scholar] [CrossRef]
- Srivastava, R.; Daulatabad, S.V.; Srivastava, M.; Janga, S.C. Role of SARS-CoV-2 in altering the RNA binding protein and miRNA directed post-transcriptional regulatory networks in humans. Int. J. Mol. Sci. 2020, 21, 7090. [Google Scholar] [CrossRef] [PubMed]
- Mukherjee, M.; Goswami, S. Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2. PLoS ONE 2020, 15, e0237559. [Google Scholar] [CrossRef] [PubMed]
- Mangukia, N.; Rao, P.; Patel, K.; Pandya, H.; Rawal, R.M. Identifying potential human and medicinal plant microRNAs against SARS-CoV-2 3′UTR region: A computational genomics assessment. Comput. Biol. Med. 2021, 136, 104662. [Google Scholar] [CrossRef] [PubMed]
- Barreda-Manso, M.A.; Nieto-Díaz, M.; Soto, A.; Muñoz-Galdeano, T.; Reigada, D.; Maza, R.M. In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3′-UTR. Int. J. Mol. Sci. 2021, 22, 6094. [Google Scholar] [CrossRef] [PubMed]
- Natarelli, L.; Parca, L.; Mazza, T.; Weber, C.; Virgili, F.; Fratantonio, D. MicroRNAs and Long Non-Coding RNAs as Potential Candidates to Target Specific Motifs of SARS-CoV-2. Noncoding RNA 2021, 7, 14. [Google Scholar] [CrossRef] [PubMed]
- Bertolazzi, G.; Cipollina, C.; Benos, P.V.; Tumminello, M.; Coronnello, C. hsa-miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 Targeting SARS-CoV-2 RNA. Front. Cell. Infect. Microbiol. 2020, 29, 586592. [Google Scholar] [CrossRef]
- Mohammadi-Dehcheshmeh, M.; Moghbeli, S.M.; Rahimirad, S.; Alanazi, I.O.; Shehri, Z.S.A.; Ebrahimie, E. A Transcription Regulatory Sequence in the 5′ Untranslated Region of SARS-CoV-2 Is Vital for Virus Replication with an Altered Evolutionary Pattern against Human Inhibitory MicroRNAs. Cells 2021, 10, 319. [Google Scholar] [CrossRef]
- Demirci, Y.M.; Saçar Demirci, M.D. Circular RNA-MicroRNA-MRNA interaction predictions in SARS-CoV-2 infection. J. Integr. Bioinform. 2021, 18, 45–50. [Google Scholar] [CrossRef]
- McDonald, J.T.; Enguita, F.J.; Taylor, D.; Griffin, R.J.; Priebe, W.; Emmett, M.R.; Sajadi, M.M.; Harris, A.D.; Clement, J.; Dybas, J.M. Role of hsa-miR-2392 in driving SARS-CoV-2 infection. Cell Rep. 2021, 37, 109839. [Google Scholar] [CrossRef]
- Hasan, M.; Ashik, A.I.; Chowdhury, M.B.; Tasnim, A.T.; Nishat, Z.S.; Hossain, T.; Ahmed, S. Computational prediction of potential siRNA and human miRNA sequences to silence orf1ab associated genes for future therapeutics against SARS-CoV-2. Inform. Med. Unlocked 2021, 24, 100569. [Google Scholar] [CrossRef]
- Banaganapalli, B.; Al-Rayes, N.; Awan, Z.A.; Alsulaimany, F.A.; Alamri, A.S.; Elango, R.; Malik, M.Z.; Shaik, N.A. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection. Comput. Biol. Med. 2021, 135, 104570. [Google Scholar] [CrossRef] [PubMed]
- Li, C.; Hu, X.; Li, L.; Li, J.H. Differential microRNA expression in the peripheral blood from human patients with COVID-19. J. Clin. Lab. Anal. 2020, 34, e23590. [Google Scholar] [CrossRef] [PubMed]
- Siniscalchi, C.; Di Palo, A.; Russo, A.; Potenza, N. Human MicroRNAs Interacting with SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation. Front. Genet. 2021, 12, 678994. [Google Scholar] [CrossRef] [PubMed]
- Garg, A.; Seeliger, B.; Derda, A.A.; Xiao, K.; Gietz, A.; Scherf, K.; Sonnenschein, K.; Pink, I.; Hoeper, M.M.; Welte, T.; et al. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur. J. Heart Fail. 2021, 23, 468–475. [Google Scholar] [CrossRef]
- Tang, H.; Gao, Y.; Li, Z.; Miao, Y.; Huang, Z.; Liu, X.; Xie, L.; Li, H.; Wen, W.; Zheng, Y.; et al. The noncoding and coding transcriptional landscape of the peripheral response in patients with COVID-19. Clin. Transl. Med. 2020, 10, e200. [Google Scholar] [CrossRef]
- Kaur, T.; Kapila, S.; Kapila, R.; Kumar, S.; Upadhyay, D.; Kaur, M.; Sharma, C. Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint. Virus Res. 2021, 294, 198275. [Google Scholar] [CrossRef]
- Saulle, I.; Garziano, M.; Fenizia, C.; Cappelletti, G.; Parisi, F.; Clerici, M.; Cetin, I.; Savasi, V.; Biasin, M. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women. Cells 2021, 10, 1788. [Google Scholar] [CrossRef]
- Mishra, R.; Banerjea, A.C. SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal hsa-miR-148a to Activate Human Microglia. Front. Immunol. 2021, 12, 656700. [Google Scholar] [CrossRef]
- Grehl, C.; Schultheiß, C.; Hoffmann, K.; Binder, M.; Altmann, T.; Grosse, I.; Kuhlmann, M. Detection of SARS-CoV-2 Derived Small RNAs and Changes in Circulating Small RNAs Associated with COVID-19. Viruses 2021, 13, 1593. [Google Scholar] [CrossRef]
- Park, J.H.; Choi, Y.; Lim, C.W.; Park, J.M.; Yu, S.H.; Kim, Y.; Han, H.J.; Kim, C.H.; Song, Y.S.; Kim, C.; et al. Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2. Cells 2021, 10, 2393. [Google Scholar] [CrossRef]
- Sabbatinelli, J.; Giuliani, A.; Matacchione, G.; Latini, S.; Laprovitera, N.; Pomponio, G.; Ferrarini, A.; Svegliati Baroni, S.; Pavani, M.; Moretti, M.; et al. Decreased serum levels of the inflammaging marker hsa-miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients. Mech. Ageing Dev. 2021, 193, 111413. [Google Scholar] [CrossRef] [PubMed]
- McDonald, J.T.; Enguita, F.J.; Taylor, D.; Griffin, R.J.; Priebe, W.; Emmett, M.R.; Sajadi, M.M.; Harris, A.D.; Clement, J.; Dybas, J.M.; et al. The Great Deceiver: Hsa-miR-2392’s Hidden Role in Driving SARS-CoV-2 Infection. bioRxiv 2021. [Google Scholar] [CrossRef]
- Centa, A.; Fonseca, A.S.; Ferreira, S.G.D.S.; Azevedo, M.L.V.; Vaz de Paula, C.B.; Nagashima, S.; Machado-Souza, C.; Miggiolaro, A.F.R.D.S.; Baena, C.P.; de Noronha, L.; et al. Deregulated miRNA expression is associated with endothelial dysfunction in post- mortem lung biopsies of COVID-19 patients. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2020, 320, L405–L412. [Google Scholar] [CrossRef]
- Fayyad-Kazan, M.; Makki, R.; Skafi, N.; El Homsi, M.; Hamade, A.; El Majzoub, R.; Hamade, E.; Fayyad-Kazan, H.; Badran, B. Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19). Infect. Genet. Evol. 2021, 94, 105020. [Google Scholar] [CrossRef] [PubMed]
- Bagheri-Hosseinabadi, Z.; Ostad Ebrahimi, H.; Bahrehmand, F.; Taghipour, G.; Abbasifard, M. The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19. Iran. J. Immunol. 2021, 18, 65–73. [Google Scholar] [CrossRef]
- Li, C.X.; Chen, J.; Lv, S.K.; Li, J.H.; Li, L.L.; Hu, X. Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 and Patients. Mediators Inflamm. 2021, 1, 6635925. [Google Scholar] [CrossRef]
- Keikha, R.; Hashemi-Shahri, S.M.; Jebali, A. The relative expression of hsa-miR-31, hsa-miR-29, hsa-miR-126, and hsa-miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization. Eur. J. Med. Res. 2021, 26, 75. [Google Scholar] [CrossRef]
- Pimenta, R.; Viana, N.I.; Dos Santos, G.A.; Candido, P.; Guimarães, V.R.; Romão, P.; Silva, I.A.; de Camargo, J.A.; Hatanaka, D.M.; Queiroz, P.G.S.; et al. hsa-miR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19. Mol. Biol. Res. Commun. 2021, 10, 141–147. [Google Scholar] [CrossRef]
- Donyavi, T.; Bokharaei-Salim, F.; Baghi, H.B.; Khanaliha, K.; Alaei Janat-Makan, M.; Karimi, B.; Sadri Nahand, J.; Mirzaei, H.; Khatami, A.; Garshasbi, S.; et al. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155–5p, and let-7b-3p in PBMC. Int. Immunopharmacol. 2021, 97, 107641. [Google Scholar] [CrossRef]
- Mirza, B.; Wang, W.; Wang, J.; Choi, H.; Chung, N.C.; Ping, P. Machine Learning and Integrative Analysis of Biomedical Big Data. Genes 2019, 10, 87. [Google Scholar] [CrossRef]
- Catalanotto, C.; Cogoni, C.; Zardo, G. MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions. Int. J. Mol. Sci. 2016, 17, 1712. [Google Scholar] [CrossRef] [PubMed]
- Pepe, G.; Guarracino, A.; Ballesio, F.; Parca, L.; Ausiello, G.; Helmer-Citterich, M. Evaluation of potential miRNA sponge effects of SARS genomes in human. Non-Coding RNA Res. 2022, 7, 48–53. [Google Scholar] [CrossRef] [PubMed]
- Nersisyan, S.; Engibaryan, N.; Gorbonos, A.; Kirdey, K.; Makhonin, A.; Tonevitsky, A. Potential role of cellular miRNAs in coronavirus-host interplay. Peer J. 2020, 8, e9994. [Google Scholar] [CrossRef] [PubMed]
- Bartoszewski, R.; Dabrowski, M.; Jakiela, B.; Matalon, S.; Harrod, K.S.; Sanak, M.; Collawn, J.F. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs. Am. J. Physiol. Lung Cell Mol. Physiol. 2020, 319, L444–L455. [Google Scholar] [CrossRef] [PubMed]
- Ryback, R.; Eirin, A. Mitochondria, a Missing Link in COVID-19 Heart Failure and Arrest? Front. Cardiovasc. Med. 2022, 8, 830024. [Google Scholar] [CrossRef]
- Domondon, M.; Nikiforova, A.B.; DeLeon-Pennell, K.Y.; Ilatovskaya, D.V. Regulation of mitochondria function by natriuretic peptides. Am. J. Physiol. Renal Physiol. 2019, 317, 1164–1168. [Google Scholar] [CrossRef]
- Wu, K.E.; Fazal, F.M.; Parker, K.R.; Zou, J.; Chang, H.Y. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus. Cell Syst. 2020, 11, 102–108.e3. [Google Scholar] [CrossRef]
- Komaroff, A.L.; Bateman, L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front. Med. 2021, 7, 606824. [Google Scholar] [CrossRef]
- Miller, B.; Silverstein, A.; Flores, M.; Cao, K.; Kumagai, H.; Mehta, H.H.; Yen, K.; Kim, S.J.; Cohen, P. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples. Sci. Rep. 2021, 11, 3. [Google Scholar] [CrossRef]
- Li, S.; Ma, F.; Yokota, T.; Garcia, G., Jr.; Palermo, A.; Wang, Y.; Farrell, C.; Wang, Y.C.; Wu, R.; Zhou, Z.; et al. Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity. JCI Insight. 2021, 6, e145027. [Google Scholar] [CrossRef]
- Clausen, T.M.; Sandoval, D.R.; Spliid, C.B.; Pihl, J.; Perrett, H.R.; Painter, C.D.; Narayanan, A.; Majowicz, S.A.; Kwong, E.M.; McVicar, R.N.; et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 2020, 183, 1043–1057.e15. [Google Scholar] [CrossRef] [PubMed]
- Kalra, R.S.; Kandimalla, R. Engaging the spikes: Heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection. Signal. Transduct. Target. Ther. 2021, 6, 39. [Google Scholar] [CrossRef] [PubMed]
- Yu, M.; Zhang, T.; Zhang, W.; Sun, Q.; Li, H.; Li, J. Elucidating the interactions between heparin/heparan sulfate and SARS-CoV-2-related proteins—An important strategy for developing novel therapeutics for the COVID-19 pandemic. Front. Mol. Biosci. 2021, 7, 628551. [Google Scholar] [CrossRef] [PubMed]
- De Pasquale, V.; Quiccione, M.S.; Tafuri, S.; Avallone, L.; Pavone, L.M. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2. Int. J. Mol. Sci. 2021, 22, 6574. [Google Scholar] [CrossRef]
- Rabaan, A.A.; Al-Ahmed, S.H.; Muhammad, J.; Khan, A.; Sule, A.A.; Tirupathi, R.; Mutair, A.A.; Alhumaid, S.; Al-Omari, A.; Dhawan, M.; et al. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines 2021, 9, 436. [Google Scholar] [CrossRef]
- Buszko, M.; Nita-Lazar, A.; Park, J.H.; Schwartzberg, P.L.; Verthelyi, D.; Young, H.A.; Rosenberg, A.S. Lessons learned: New insights on the role of cytokines in COVID-19. Nat. Immunol. 2021, 22, 404–411. [Google Scholar] [CrossRef]
- Costela-Ruiz, V.J.; Illescas-Montes, R.; Puerta-Puerta, J.M.; Ruiz, C.; Melguizo-Rodríguez, L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020, 54, 62–75. [Google Scholar] [CrossRef]
- Montazersaheb, S.; Hosseiniyan Khatibi, S.M.; Hejazi, M.S.; Tarhriz, V.; Farjami, A.; Ghasemian Sorbeni, F.; Farahzadi, R.; Ghasemnejad, T. COVID-19 infection: An overview on cytokine storm and related interventions. Virol. J. 2022, 19, 92. [Google Scholar] [CrossRef]
- Blanco-Melo, D.; Nilsson-Payant, B.E.; Liu, W.C.; Uhl, S.; Hoagland, D.; Møller, R.; Jordan, T.X.; Oishi, K.; Panis, M.; Sachs, D.; et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 2020, 181, 1036–1045. [Google Scholar] [CrossRef]
- Wilson, J.C.; Kealy, D.; James, S.R.; Plowman, T.; Newling, K.; Jagger, C.; Filbey, K.; Mann, E.R.; Konkel, J.E.; Menon, M.; et al. Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19. iScience 2022, 25, 103672. [Google Scholar] [CrossRef]
- Garcia-Giralt, N.; Du, J.; Marin-Corral, J.; Bódalo-Torruella, M.; Blasco-Hernando, F.; Muñoz-Bermúdez, R.; Clarós, M.; Nonell, L.; Perera-Bel, J.; Fernandez-González, M.; et al. Circulating microRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection. Sci. Rep. 2022, 12, 6929. [Google Scholar] [CrossRef] [PubMed]
- Abusalah, M.A.H.; Khalifa, M.; Al-Hatamleh, M.A.I.; Jarrar, M.; Mohamud, R.; Chan, Y.Y. Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm. J. Pers. Med. 2022, 12, 386. [Google Scholar] [CrossRef] [PubMed]
- Yuan, X.; Yao, Z.; Wu, J.; Zhou, Y.; Shan, Y.; Dong, B.; Zhao, Z.; Hua, P.; Chen, J.; Cong, Y. G1 phase cell cycle arrest induced by SARS-CoV 3a protein via the cyclin D3/pRb pathway. Am. J. Respir. Cell Mol. Biol. 2007, 37, 9–19. [Google Scholar] [CrossRef]
- Yuan, X.; Shan, Y.; Zhao, Z.; Chen, J.; Cong, Y. G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells. Virol. J. 2005, 2, 66. [Google Scholar] [CrossRef] [PubMed]
- Yuan, X.; Wu, J.; Shan, Y.; Yao, Z.; Dong, B.; Chen, B.; Zhao, Z.; Wang, S.; Chen, J.; Cong, Y. SARS coronavirus 7a protein blocks cell cycle progression at G0/G1 phase via the cyclin D3/pRb pathway. Virology 2006, 346, 74–85. [Google Scholar] [CrossRef]
- Su, M.; Chen, Y.; Qi, S.; Shi, D.; Feng, L.; Sun, D. A Mini-Review on Cell Cycle Regulation of Coronavirus Infection. Front. Vet. Sci. 2020, 7, 586826. [Google Scholar] [CrossRef]
- Surjit, M.; Liu, B.; Chow, V.T.; Lal, S.K. The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells. J. Biol. Chem. 2006, 281, 10669–10681. [Google Scholar] [CrossRef]
- Wang, W.; Chen, J.; Hu, D.; Pan, P.; Liang, L.; Wu, W.; Tang, Y.; Huang, X.R.; Yu, X.; Wu, J.; et al. SARS-CoV-2 N Protein Induces Acute Kidney Injury via Smad3-Dependent G1 Cell Cycle Arrest Mechanism. Adv. Sci. 2022, 9, 2103248. [Google Scholar] [CrossRef]
- Liu, X.; Lou, L.; Zhou, L. Molecular Mechanisms of Cardiac Injury Associated With Myocardial SARS-CoV-2 Infection. Front. Cardiovasc. Med. 2022, 8, 643958. [Google Scholar] [CrossRef]
- Wang, Z.N.; Yang, X.S.; Sun, J.; Zhao, J.C.; Zhong, N.S.; Tang, X.X. Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses. iScience 2022, 25, 103967. [Google Scholar] [CrossRef]
- Sun, F.; Mu, C.; Kwok, H.F.; Xu, J.; Wu, Y.; Liu, W.; Sabatier, J.M.; Annweiler, C.; Li, X.; Cao, Z.; et al. Capivasertib restricts SARS-CoV-2 cellular entry: A potential clinical application for COVID-19. Int. J. Biol. Sci. 2021, 17, 2348–2355. [Google Scholar] [CrossRef] [PubMed]
- Appelberg, S.; Gupta, S.; Svensson Akusjärvi, S.; Ambikan, A.T.; Mikaeloff, F.; Saccon, E.; Végvári, Á.; Benfeitas, R.; Sperk, M.; Ståhlberg, M.; et al. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerg. Microbes Infect. 2020, 9, 1748–1760. [Google Scholar] [CrossRef] [PubMed]
- Pelzl, L.; Singh, A.; Funk, J.; Witzemann, A.; Zlamal, J.; Marini, I.; Weich, K.; Abou-Khalel, W.; Hammer, S.; Uzun, G.; et al. Antibody-mediated procoagulant platelet formation in COVID-19 is AKT dependent. J. Thromb. Haemost. 2022, 20, 387–398. [Google Scholar] [CrossRef] [PubMed]
- Langnau, C.; Rohlfing, A.K.; Gekeler, S.; Günter, M.; Pöschel, S.; Petersen-Uribe, Á.; Jaeger, P.; Avdiu, A.; Harm, T.; Kreisselmeier, K.P.; et al. Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients with Coronary Artery Disease and COVID-19. Arter. Thromb. Vasc. Biol. 2021, 41, 2080–2096. [Google Scholar] [CrossRef]
- Seizer, P.; Ungern-Sternberg, S.N.; Schönberger, T.; Borst, O.; Münzer, P.; Schmidt, E.M.; Mack, A.F.; Heinzmann, D.; Chatterjee, M.; Langer, H.; et al. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 2015, 35, 655–663. [Google Scholar] [CrossRef]
- Khezri, M.R.; Varzandeh, R.; Ghasemnejad-Berenji, M. The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy. Cell. Mol. Biol. Lett. 2022, 27, 6. [Google Scholar] [CrossRef]
- Shi, X.; Wang, J.; Lei, Y.; Cong, C.; Tan, D.; Zhou, X. Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review). Mol. Med. Rep. 2019, 19, 4529–4535. [Google Scholar] [CrossRef]
- Margaria, J.P.; Moretta, L.; Alves-Filho, J.C.; Hirsch, E. PI3K Signaling in Mechanisms and Treatments of Pulmonary Fibrosis Following Sepsis and Acute Lung Injury. Biomedicines 2022, 10, 756. [Google Scholar] [CrossRef]
- Zhang, X.L.; Xing, R.G.; Chen, L.; Liu, C.R.; Miao, Z.G. PI3K/Akt signaling is involved in the pathogenesis of bleomycin-induced pulmonary fibrosis via regulation of epithelial-mesenchymal transition. Mol. Med. Rep. 2016, 14, 5699–5706. [Google Scholar] [CrossRef]
- Wang, J.; Hu, K.; Cai, X.; Yancg, B.; He, Q.; Wang, J.; Weng, Q. Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm. Sin. B 2022, 12, 18–32. [Google Scholar] [CrossRef]
- Kolesova, O.; Vanaga, I.; Laivacuma, S.; Derovs, A.; Kolesovs, A.; Radzina, M.; Platkajis, A.; Eglite, J.; Hagina, E.; Arutjunana, S.; et al. Intriguing findings of liver fibrosis following COVID-19. BMC Gastroenterol. 2021, 21, 370. [Google Scholar] [CrossRef] [PubMed]
- Lei, Y.; Wang, Q.L.; Shen, L.; Tao, Y.Y.; Liu, C.H. MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway. Clin. Res. Hepatol. Gastroenterol. 2019, 43, 575–584. [Google Scholar] [CrossRef] [PubMed]
- Sticht, C.; De La Torre, C.; Parveen, A.; Gretz, N. miRWalk: An online resource for prediction of microRNA binding sites. PLoS ONE 2018, 13, e0206239. [Google Scholar] [CrossRef] [PubMed]
- Doncheva, N.T.; Morris, J.H.; Gorodkin, J.; Jensen, L.J. Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. J. Proteome Res. 2019, 18, 623–632. [Google Scholar] [CrossRef]
Downregulated microRNAs | References | Upregulated microRNAs | References |
---|---|---|---|
hsa-miR-1226-3p | Farr et al., 2021 [19] | hsa-let-7e-5p | Farr et al., 2021 [19] |
hsa-miR-1275 | hsa-let-7f-5p | ||
hsa-miR-145-3p | hsa-miR-103a-3p | ||
hsa-miR-210-3p | hsa-miR-142-3p | ||
hsa-miR-3065-3p | hsa-miR-148a-3p | ||
hsa-miR-3617-5p | hsa-miR-193a-5p | ||
hsa-miR-4772-3p | hsa-miR-195-5p | ||
hsa-miR-491-5p | hsa-miR-6721-5p | ||
hsa-miR-627-5p | hsa-miR-92 | ||
hsa-miR-651-5p | hsa-miR-206 | ||
hsa-miR-664b-3p | hsa-miR-185-5p | Grehl et al., 2021 [50] | |
hsa-miR-766-3p | hsa-miR-320a-3p | ||
hsa-miR-122b-5p | Grehl et al., 2021 [50] | hsa-miR-320b | |
hsa-miR-144-5p | hsa-miR-320c | ||
hsa-miR-193b-3p | hsa-miR-320d | ||
hsa-miR-29b-3p | hsa-miR-4742-3p | ||
hsa-miR-454-3p | hsa-miR-125b-5p | Li et al., 2021 [57] | |
hsa-miR-144-3p | Li et al., 2021 [57] | hsa-miR-142-5p | |
hsa-miR-183-5p | hsa-miR-16-2-3p | ||
hsa-miR-18a-5p | hsa-miR-15b-5p | Tang et al., 2020 [46] | |
hsa-miR-18b-5p | hsa-miR-486-5p | ||
hsa-miR-20a-5p | hsa-miR-15a-5p | Fayyad-Kazan et al., 2021 [55] | |
hsa-miR-3613-5p | hsa-miR-19a-3p | ||
hsa-miR-146a-5p | Tang et al., 2020 [46] | hsa-miR-19b-3p | |
hsa-miR-181a-2-3p | hsa-miR-23a-3p | ||
hsa-miR-17-5p | Fayyad-Kazan et al., 2021 [55] | hsa-miR-194-5p | |
hsa-miR-146a-3p | Donyavi et al., 2021 [60] |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Moatar, A.I.; Chis, A.R.; Marian, C.; Sirbu, I.-O. Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease. Int. J. Mol. Sci. 2022, 23, 9239. https://doi.org/10.3390/ijms23169239
Moatar AI, Chis AR, Marian C, Sirbu I-O. Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease. International Journal of Molecular Sciences. 2022; 23(16):9239. https://doi.org/10.3390/ijms23169239
Chicago/Turabian StyleMoatar, Alexandra Ioana, Aimee Rodica Chis, Catalin Marian, and Ioan-Ovidiu Sirbu. 2022. "Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease" International Journal of Molecular Sciences 23, no. 16: 9239. https://doi.org/10.3390/ijms23169239